Webinar | April 15, 2024

Success Planning For An Original NDA/BLA Submission

This comprehensive webinar provides an in-depth examination of New Drug Applications (NDAs) and Biologics License Applications (BLAs), essential for pharmaceutical companies seeking approval for new drugs and biologics. Participants will gain crucial knowledge and resources to navigate the NDA/BLA process effectively.

Led by experienced experts in regulatory strategy, operations, and program leadership, attendees will learn successful planning strategies for original NDA/BLA submissions. Topics covered include initiation triggers, team coordination, submission processes, and Electronic Submission Gateway (ESG) utilization.

At Halloran, we're dedicated to improving human health by providing innovative therapies. This webinar aligns with our mission by empowering pharmaceutical professionals to develop and approve groundbreaking treatments, addressing unmet medical needs worldwide.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader